Delivery Order W81XWH15D0037-0001
Award Date
11/1/16
Potential Completion Date
8/17/18
Potential Value
$1.7M
Federal Agency
Medical Command
Awardee
Dynport Vaccine Company LLC
Ultimate Awardee
General Dynamics Corp
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Fort Detrick, MD 21702, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award with a potential value of $139,426.00, issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The contract is a Delivery Order under the "Therapeutics Against Infectious Diseases Phase 1" master IDIQ contract. The award is for a PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The $222,661 award is a delivery order under the Therapeutics Against Infectious Diseases Phase 1 IDIQ contract, which funds Phase 1 clinical trials for therapeutics against infectious diseases. The contract does not have a set-aside designation. This order is for Dynport to conduct Phase 1...
This is a $2,265,501.00 delivery order contract awarded to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Early Phase Clinical Trial Units (EPCTU) IDIQ contract vehicle. The contract is for cost plus fixed fee services to support early phase clinical trials, with a period of performance through July 15, 2025. The contract does not have a set-aside designation. Dynport Vaccine Company has...
This is a $28,836,234.91 firm fixed price contract awarded by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The contract is for stability testing of critical material lots for the rBV A/B and rF1V vaccine programs, which are in advanced development to protect against botulism and pneumonic plague. The contract has a completion date of December 15, 2027. Dynport Vaccine Company...
This is a cost-plus-fixed-fee definitive contract awarded by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The $258,064,432.13 contract is for program reporting and technical services in support of the development and delivery of an FDA-licensed human plasma-derived butyrylcholinesterase (HuBChE) product. The award does not have a set-aside designation. Dynport Vaccine Company...
This is a delivery order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery, indefinite quantity (IDIQ) contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The order, valued at $5,167,891.00, funds a Phase 1 clinical trial unit for therapeutic candidates against infectious diseases. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General...
This is a Delivery Order under the $3,500.00 Diagnostic Pre-Clinical Services Program IDIQ contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp that provides biopharmaceutical research, development, manufacturing, and testing services. This Delivery Order supports the development of candidate...
This is a delivery order award to Dynport Vaccine Company LLC (DVC), a subsidiary of General Dynamics Corp, under the $36 million Diagnostic Pre-Clinical Services Program IDIQ contract with the National Institute of Allergy and Infectious Diseases (NIAID). The task order is for a 7-year period of performance with a ceiling value of $3,500. It does not have a set-aside designation. Under this contract, DVC will provide a range of research, development, manufacturing, and testing services to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.2 million delivery order contract to Dynport Vaccine Company LLC DVC Segment Division for the evaluation of cell lines producing a monoclonal antibody, and production and characterization of a cGMP master cell bank. Dynport Vaccine Company LLC DVC Segment Division, a subsidiary of General Dynamics Corp., will perform this work under its Preclinical Services...
This is a federal contract award by the U.S. Army Medical Command (MEDCOM) to General Dynamics Information Technology, Inc. (GDIT), a subsidiary of General Dynamics Corporation. The $158,410.92 cost-plus-fixed-fee delivery order contract supports the Fiscal Year 2016 Peer Reviewed Alzheimer's Research Program (PRARP) with services to be performed at Fort Detrick, Maryland. The contract is not designated as a set-aside. GDIT, as the prime contractor, will leverage its expertise in IT services,...